Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
53.1M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
34.5M
-
Shares change
-
+1.19M
-
Total reported value, excl. options
-
$2.55B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.35
-
Number of buys
-
53
-
Number of sells
-
-48
-
Price
-
$73.86
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2021
130 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q3 2021.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.5M shares
of 53.1M outstanding shares and own 64.97% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), Vivo Capital, LLC (4.22M shares), WELLINGTON MANAGEMENT GROUP LLP (3.87M shares), Logos Global Management LP (3.16M shares), VANGUARD GROUP INC (1.68M shares), BlackRock Inc. (1.37M shares), FMR LLC (1.26M shares), JANUS HENDERSON GROUP PLC (1.03M shares), Cormorant Asset Management, LP (1.01M shares), and Redmile Group, LLC (864K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.